EcoDrugPlus

Ensembl ID : ENSCSAVG00000011550
Gene Symbol: -
1 Cross references
185 Possible Orthologues:

Ensembl ID : ENSCSAVG00000011606
Gene Symbol: -
1 Cross references
204 Possible Orthologues:

Ensembl ID : ENSCSAVG00000011609
Gene Symbol: -
1 Cross references
389 Possible Orthologues:

Ensembl ID : ENSCSAVG00000011635
Gene Symbol: -
1 Cross references
341 Possible Orthologues:

Ensembl ID : ENSCSAVG00000011661
Gene Symbol: -
1 Cross references
1156 Possible Orthologues:

Ensembl ID : ENSCSAVG00000011787
Gene Symbol: -
1 Cross references
304 Possible Orthologues:

Ensembl ID : ENSCSAVG00000011799
Gene Symbol: -
1 Cross references
272 Possible Orthologues:

Ensembl ID : ENSCSAVG00000000862
Gene Symbol: -
1 Cross references
182 Possible Orthologues:

Ensembl ID : ENSCSAVG00000000920
Gene Symbol: -
1 Cross references
183 Possible Orthologues:

Ensembl ID : ENSCSAVG00000004832
Gene Symbol: -
1 Cross references
183 Possible Orthologues:

Ensembl ID : ENSCSAVG00000008810
Gene Symbol: -
1 Cross references
175 Possible Orthologues:

Ensembl ID : ENSCSAVG00000010763
Gene Symbol: -
1 Cross references
248 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).